Pancreatic Cancer Research

ResearcherNational Institute for Health and Care ResearchActive in the last 2 years

Dileep N. Lobo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1187-5796; OpenAlex author ID A5003275621. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. Co-author DOI 10.1016/j.gastha.2024.04.005↗
  2. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-gluco… Co-author DOI 10.3310/hta22070↗
  3. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Last author DOI 10.1016/j.clnu.2015.08.005↗
  4. Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Last author DOI 10.1016/j.clnu.2016.03.006↗
  5. The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays. Last author DOI 10.1186/1471-2407-13-436↗
  6. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-010-1381-x↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nilanjana Tewari · 3 shared papers, 2013–2016 · strength 0.17
  2. George A. Poultsides · 1 shared paper, 2024 · strength 0.17
  3. Christina Vorvis · 1 shared paper, 2024 · strength 0.17
  4. Maria Hatziapostolou · 1 shared paper, 2024 · strength 0.17
  5. Dimitrios Iliopoulos · 1 shared paper, 2024 · strength 0.17
  6. Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.17
  7. Mouad Edderkaoui · 1 shared paper, 2024 · strength 0.17
  8. David W. Dawson · 1 shared paper, 2024 · strength 0.17
  9. Kenneth C. H. Fearon · 2 shared papers, 2016 · strength 0.12
  10. Katie E. Rollins · 2 shared papers, 2016 · strength 0.12
  11. Colin Johnson · 1 shared paper, 2018 · strength 0.05
  12. Robert Peter Sutcliffe · 1 shared paper, 2018 · strength 0.05
  13. Paula Ghaneh · 1 shared paper, 2018 · strength 0.05
  14. Brian Ritchie Davidson · 1 shared paper, 2018 · strength 0.05
  15. Colin J. McKay · 1 shared paper, 2018 · strength 0.05
  16. Andrew Malvern Smith · 1 shared paper, 2018 · strength 0.05
  17. Debashis Sarker · 1 shared paper, 2018 · strength 0.05
  18. John P. Neoptolemos · 1 shared paper, 2018 · strength 0.05
  19. Stephen P. Pereira · 1 shared paper, 2018 · strength 0.05
  20. David Cunningham · 1 shared paper, 2018 · strength 0.05
  21. Christopher Michael Halloran · 1 shared paper, 2018 · strength 0.05
  22. Hemant Mahendrakumar Kocher · 1 shared paper, 2018 · strength 0.05
  23. Mohammad Abu Hilal · 1 shared paper, 2018 · strength 0.05
  24. Richard Charnley · 1 shared paper, 2018 · strength 0.05
  25. Mohammad Ilyas · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.